Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Mantle-Cell × Cisplatin × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 79 Squamous Cell Carcinoma of Head and Neck 43 Lung Neoplasms 34 Urinary Bladder Neoplasms 21 Oropharyngeal Neoplasms 17 Parkinson Disease 4, Autosomal Dominant Lewy Body 16 Ovarian Neoplasms 14 Head and Neck Neoplasms 14 Carcinoma 13 Biliary Tract Neoplasms 13 Uterine Cervical Neoplasms 12 Neoplasm Metastasis 12 Colorectal Neoplasms 12 Carcinoma, Squamous Cell 12 Nasopharyngeal Carcinoma 11 Esophageal Squamous Cell Carcinoma 11 Laryngeal Neoplasms 10 Carcinoma, Transitional Cell 10 Stomach Neoplasms 9 Mouth Neoplasms 9 Neoplasms 8 Mesothelioma, Malignant 8 Cholangiocarcinoma 8 Gallbladder Neoplasms 7 Esophageal Neoplasms 7 Medulloblastoma 6 Hypopharyngeal Neoplasms 6 Triple Negative Breast Neoplasms 5 Neuroblastoma 5 Adenocarcinoma 5

Interventions

Rituximab 25 acalabrutinib 14 Cyclophosphamide 13 ibrutinib 12 venetoclax 11 zanubrutinib 9 Magnetic Resonance Spectroscopy 9 pirtobrutinib 8 obinutuzumab 8 glofitamab 8 fludarabine 8 Lenalidomide 8 CT-P10 8 Bendamustine Hydrochloride 8 Specimen Handling 7 Cytarabine 6 Biopsy 6 fludarabine phosphate 5 brexucabtagene autoleucel 4 Vincristine 4 Doxorubicin 4 Prednisone 3 Cyclosporine 3 palbociclib 2 Whole-Body Irradiation 2 Therapeutics 2 Stem Cell Transplantation 2 Mycophenolic Acid 2 Methotrexate 2 Leukapheresis 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02858804 2026-02-11

BDH-MCL01

Institute of Hematology & Blood Diseases Hospital, China

Phase 4 Completed

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡